Study on the Effects of DA-9701 on Gastrointestinal Motility on Healthy Adult Volunteers

Inclusion criteria

• Healthy adults of either sex, at least 20 years of age
• Having no abdominal discomfort or pain
• No diseases diagnosed by screening gastroduodenoscopy
• Having given voluntary written consent

Exclusion criteria

• Currently participating or having participated in another drug trial within four weeks of trial start.
• Women of childbearing age who are either pregnant, breast-feeding or not under proper contraceptive methods.
• A history of surgery which may affect gastrointestinal motility.
• Subjects with gastrointestinal bleeding, mechanical obstruction or perforation.
• Subjects with irritable bowel syndrome or inflammatory bowel disease.
• Subjects with serious conditions involving the liver, kidneys, heart, lung or endocrinology system.
• Psychiatric disease patients, substance abuse subjects such as alcohol or drugs.
• Subjects who have taken drugs that may affect the study outcome such as antibiotics, corticosteroids or NSAIDS within 1 month or motility agents, H2 receptor blockers, proton pump inhibitors, anticholinergics, erythromycin or antipsychotics within 2 weeks.
• Other reasons that the investigator considers valid.